 |
| Stem Cell Treatments – A New Horizon |
| ENS in alliance with Shenzhen Beike Biotechnology Co. Ltd. offers a one-stop-solution for Stem Cell Treatment for various medical conditions As of July 1st, 2007 Beike had treated over 1,800 patients with stem cell injections for diseases like Alzheimers, Ataxia, Autism, ALS, Brain Trauma, Cerebral Infarction, Cerebral Hemorrhage, Cerebral Palsy, Guillain-Barre, diabetic foot/arteriosclerosis, Encephalatropy, and Spinal Cord Injury. About Bieke Bio-Tech Beike is a biotechnology company that was founded with capital from Beijing University, Hong Kong University of Science and Technology and Shenzhen City Hall. It is also supported with funds from the China State National Fund. The research and clinical work comes as a collaboration of Beijing University, Hong Kong University of Science & Technology, No. 3 Army Medical University, Zhongshan Medical University, Guiyang Medical College and Zhengzhou University. Throughout all its collaborating laboratories, Beike has over 60 Ph.D. researchers focusing on stem cell research. The company was formed in January of 2005 after the collaborating scientists felt comfortable enough with their years of research and clinical experience to begin treating patients with stem cells on a commercial scale. The management, researchers and doctors have been focused on stem cell and other biomedical research since 1999. They have been treating patients with stem cell injections since 2001. As of June 1st, 2005, Beike had treated over 1,000 patients with stem cell injections for diseases like Alzheimers, Ataxia, Autism, ALS, Brain Trauma, Cerebral Infarction, Cerebral Hemorrhage, Cerebral Palsy, Guillain-Barre, diabetic foot/arteriosclerosis, Encephalatropy, and Spinal Cord Injury. Beike currently supplies stem cells for treatment at hospitals in Shenyang, Qingdao, Shenzhen and Zhengzhou concentrating on using cord blood stem cells for treatment. They treat foreign patients at Nanshan hospital in Shenzhen and 463 Hospital in Shenyang. The stem cells are delivered through IV, injections into the spinal cord fluid and surgical injections in some cases of spinal cord injury. Except for the surgical injections of the stem cells, the treatments are done as outpatient procedures. Beike’s main research labs are located in Shenyang, Shenzhen, Zhengzhou and Hainan with support from scientists from all of the collaborative universities. Beike partners with the blood banks in each city that their labs reside in to certify their stem cells are pure and disease free. Beike employs a double check system, which consists of their quality control technicians checking a second time for infectious diseases before beginning the cultivation process. In Shenzhen, their lab is at the Shenzhen Hi-tech Industrial Zone, which is one of the five large industrial zones with key focus from the Chinese central Government. With the support of the Shenzhen City Hall and the Shen Zhen Hi-tech industrial zone, Beike has been able to develop extremely rapidly. Beike is one of the leading expert groups in China for separating purifying, nurturing, and multiplying embryonic, fetal, adult and most importantly – cord blood stem cells. Beike has been able to grow human organ cells as well, which will pave the way for future cures. Beike’s greatest strength and what differentiates it from other research initiatives is that Beike specializes in clinical applications. There are a lot of patients in countries around the world who could have a better quality of life and even extend their lives with the technology available but don’t have the chance because of politics, religion and bureaucracy. Beike’s goal is to help those people. Beike takes the most advanced biotechnological research in the world, specifically stem cell therapy, and applies it clinically at a rapid pace. Medical Conditions treatable using Stem Cell Treatment • Alzheimer’s • Arteriosclerosis and Atherosclerosis • Ataxia, Friedreich’s • Autism • Cerebral Palsy • Coronary Artery and Heart Disease • Chronic Lung Disease in Infants • Coronary Artery Disease • Dilated Cardiomyopathy • Heart Failure • Juvenile Rheumatoid Arthritis • Multiple Sclerosis (MS) • Muscular Dystrophy, Duchenne’s • Peripheral Arterial Disease • Rhett’s Syndrome • Spinal Muscular Atrophy • Spinal Cerebellar Ataxia • Spinal Cord Injury Patients Experience with Stem Cell Treatment under Beike Biotech Beike in the News For further insight into Beike Biotech and Stem Cell Treatment please visit us at Beike Biotech For any further queries, Kindly fill in the Feedback Form |